Biopharmaceutical stocks that have lagged behind the broader market may finally have their day in the sun. BofA Securities ...

Heavy AI investments and the tariffs uncertainty have been putting pressure on the technology and growth sector.

As the U.S. stock market faces a sell-off driven by concerns over tariffs and economic uncertainty, investors are increasingly looking for opportunities that can offer resilience and potential growth.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

ArriVent BioPharma (NASDAQ:AVBP – Get Free Report) is one of 1,068 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its competitors? We ...

Guggenheim began coverage on shares of ArriVent BioPharma (NASDAQ:AVBP – Get Free Report) in a research note issued to investors on Monday, MarketBeat.com reports. The brokerage set a “buy” rating and ...

Auguston kicked off an animated session titled “The People Factor” by outlining all the ways in which the CEO role in ...

Officers, beneficial owners, and other insiders have shelled out more than $10 million on each of these four biotech stocks ...

Artificial intelligence (AI) and the Internet of Things (IoT) are about to revolutionize the biopharmaceutical industry.

Concentra Biosciences offers $3/share + CVR for Acelyrin, outperforming Alumis' bid. Read why I rate SLRN stock a Sell at ...

PharmaCord is a Jeffersonville, Indiana-based provider of patient services for the biopharmaceutical industry, and Mercalis, a Morrisville, North Carolina-based provider of life sciences and ...